Physician profile
Ernest Layton
NPI 1083621684
$3,826.82
in general payments reported to CMS, 2019-2025
10 companies · $696 in 2025
The $696 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $549 · 2021: $352 · 2022: $635 · 2023: $295 · 2024: $774 · 2025: $696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,763.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $1,045.36 | 2020-2022 | |
| Revance Therapeutics, INC. | $1,034.76 | 2024-2025 | Daxxify |
| Apyx Medical Corporation | $418.07 | 2019-2020 | |
| Abbvie INC. | $377.07 | 2023-2025 | |
| Integra Lifesciences Corporation | $312.96 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Mentor Worldwide LLC | $255.22 | 2021-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $241.22 | 2019-2022 | |
| Galderma Laboratories, L.P. | $109.58 | 2020-2022 | |
| Merz North America, INC. | $18.95 | 2019 | |
| Smith+Nephew, INC. | $13.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernest Layton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.